AVITA MEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.37 USD | +5.28% |
|
+11.55% | -31.71% |
| Apr. 17 | Wilsons Downgrades Avita Medical to Market-Weight From Overweight; Price Target is AU$3.03 | MT |
| Apr. 11 | BTIG Research Downgrades Avita Medical to Neutral From Buy | MT |
Evolution of the average Target Price on AVITA Medical, Inc.
Price target over the last 5 years
History of analyst recommendation changes
42e9dbebba248d23a3dc50b2b36366e1.P9R6guwfVdaKecYBt3ZEJP2jMoQteMsyq9Q24R4CE4Q.Z45NyYNbHLH4IZdijjt2Xbbaa8MASY1L6r5ju0s0csBcsyrR1SoMj9A3iw~0a4bec854510bd0565964920508cfdb1
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
14.17
AUD
Average target price
39.74
AUD
Spread / Average Target
+180.44%
High Price Target
61.65
AUD
Spread / Highest target
+335.05%
Low Price Target
32.22
AUD
Spread / Lowest Target
+127.36%
Consensus detail
Consensus revision (last 18 months)
Analysts covering AVITA Medical, Inc.
| Wilsons | |
| BTIG | |
| Piper Sandler | |
| Cantor Fitzgerald |
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
- Stock Market
- Equities
- RCEL Stock
- Consensus AVITA Medical, Inc.